Braun Stacey Associates Inc. Has $23.91 Million Holdings in Danaher Co. (NYSE:DHR)

Braun Stacey Associates Inc. decreased its stake in Danaher Co. (NYSE:DHR - Free Report) by 2.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 86,007 shares of the conglomerate's stock after selling 2,179 shares during the period. Braun Stacey Associates Inc.'s holdings in Danaher were worth $23,912,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of DHR. Quest Partners LLC acquired a new position in shares of Danaher during the 3rd quarter worth approximately $1,941,000. Aljian Capital Management LLC acquired a new position in Danaher during the third quarter worth $652,000. Atlanta Consulting Group Advisors LLC bought a new stake in Danaher during the third quarter worth $267,000. Accredited Investors Inc. acquired a new stake in Danaher in the third quarter valued at $278,000. Finally, River Street Advisors LLC grew its position in shares of Danaher by 2.7% in the 3rd quarter. River Street Advisors LLC now owns 2,486 shares of the conglomerate's stock valued at $691,000 after acquiring an additional 65 shares during the period. Institutional investors and hedge funds own 79.05% of the company's stock.

Analyst Ratings Changes

A number of brokerages have weighed in on DHR. Wells Fargo & Company started coverage on Danaher in a research report on Tuesday, August 27th. They set an "equal weight" rating and a $280.00 price target on the stock. Evercore ISI increased their price target on Danaher from $275.00 to $278.00 and gave the company an "outperform" rating in a research note on Tuesday, October 1st. StockNews.com raised shares of Danaher from a "hold" rating to a "buy" rating in a research report on Wednesday, November 6th. Stephens restated an "overweight" rating and set a $315.00 target price on shares of Danaher in a research note on Wednesday, October 23rd. Finally, Leerink Partners upped their price target on shares of Danaher from $275.00 to $280.00 and gave the company an "outperform" rating in a research note on Wednesday, July 24th. Five research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $287.16.

Danaher Price Performance

Shares of NYSE:DHR traded down $0.96 during midday trading on Monday, hitting $229.54. The stock had a trading volume of 2,322,188 shares, compared to its average volume of 2,758,141. The company's 50-day moving average price is $262.20 and its 200-day moving average price is $260.57. Danaher Co. has a fifty-two week low of $207.63 and a fifty-two week high of $281.70. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $165.79 billion, a P/E ratio of 43.99, a price-to-earnings-growth ratio of 4.24 and a beta of 0.85.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm had revenue of $5.80 billion during the quarter, compared to analysts' expectations of $5.59 billion. During the same period in the prior year, the company earned $2.02 earnings per share. The company's quarterly revenue was up 3.1% on a year-over-year basis. As a group, equities research analysts predict that Danaher Co. will post 7.51 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.47%. Danaher's dividend payout ratio (DPR) is currently 20.61%.

Insider Activity

In related news, SVP Georgeann Couchara sold 952 shares of the firm's stock in a transaction on Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the sale, the senior vice president now owns 4,212 shares of the company's stock, valued at $1,130,374.44. This trade represents a 18.44 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 11.10% of the stock is currently owned by corporate insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.